Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

The weight loss conversation has been transformed in recent years by the rise of GLP-1 medications—drugs originally developed ...

Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...

More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

Axios Visuals Louisiana women are more likely to be prescribed GLP-1 weight-loss drugs than the state's men, new data shows. Why it matters: This is another cultural moment when women, especially ...

GLP-1 drugs, such as Ozempic and the combination drug tirzepatide also included in the study, mimic a natural hormone known as glucagon-like peptide-1 to help regulate blood sugar and insulin levels.